Exact Mass: 304.9680184
Exact Mass Matches: 304.9680184
Found 105 metabolites which its exact mass value is equals to given mass value 304.9680184
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
5-[(E)-(6-Bromo-1H-indole-3-yl)methylene]imidazolidine-2,4-dione
Acetamide,2,2,2-trichloro-N-[3-(trifluoromethyl)phenyl]-
C9H5Cl3F3NO (304.93888060000006)
Sodium risedronate
C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
5-Chloro-2-methyl-3-(3-sulfopropyl)benzothiazolium,inner salt
2-Methyl-2-propanyl (2-bromo-4-chlorophenyl)carbamate
C11H13BrClNO2 (304.98181280000006)
2-[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]aniline
3-Bromo-N-(tert-butyl)-5-methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
5-(3-bromophenyl)thieno[2,3-d]pyrimidin-4-amine
C12H8BrN3S (304.96222680000005)
(4-bromophenyl)-(3-nitrophenyl)methanone
C13H8BrNO3 (304.96875180000006)
3-Ethyl-2-Methylbenzothiazolium Iodide
C10H12INS (304.97351820000006)
4-(2-PYRIDINYLOXY)BENZENESULFONYLCHLORIDEHYDROCHLORIDE
ETHYL 3-(5-BROMO-2-METHYL-4-NITRO-1H-IMIDAZOL-1-YL)PROPANOATE
C9H12BrN3O4 (305.00111319999996)
3-bromo-7-pyridin-3-ylthieno[3,2-c]pyridin-4-amine
C12H8BrN3S (304.96222680000005)
2-BROMO-3-CHLOROPHENYL N,N-DIETHYLCARBAMATE
C11H13BrClNO2 (304.98181280000006)
4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole-5-carbonyl chloride
n-t-butyl 3-bromo-4-methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
6-bromo-3-chloro-N-(oxan-4-ylmethyl)pyrazin-2-amine
7-BROMO-1,2,3,4-TETRAHYDRO-ACRIDINE-9-CARBOXYLICACID
2-(4-methoxy-phenyl)-imidazo[1,2-a]pyrimidine monohydrobromine
ETHYL 2-[(4,5-DICHLORO-1H-IMIDAZOL-1-YL)METHYL]-1,3-THIAZOLE-4-CARBOXYLATE
3-chloro-5-cyclopropyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxylic acid
2-Bromo-N-pentylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
ETHYL 2-CHLORO-2-(2-(4-CHLORO-2-NITROPHENYL)HYDRAZONO)ACETATE
C10H9Cl2N3O4 (304.99700939999997)
3-(6-Bromopyridin-2-yl)-4-methyl-benzoic acid methyl ester
[2-(5-BROMO-THIOPHEN-2-YL)-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER
C11H16BrNO2S (305.00850560000003)
4-Bromo-6-methoxy-2-(trifluoromethyl)quinoline
C11H7BrF3NO (304.96630680000004)
3-(2-Amino-4-pyrimidinyl)-6-bromo-1H-pyrrolo[2,3-b]pyridin-4-ol
tris(acetonitrile)tricarbonylmolybdenum
C9H9MoN3O3 (304.96979340000007)
4-(Pyridin-3-yloxy)benzene-1-sulfonyl chloride hydrochloride
5-(4-bromophenyl)thieno[2,3-d]pyrimidin-4-amine
C12H8BrN3S (304.96222680000005)
2-(5-BROMO-THIOPHEN-2-YL)-2,3-DIHYDRO-BENZOFURAN-5-CARBONITRILE
C13H8BrNOS (304.95099380000005)
6-Bromo-4-methoxy-2-(trifluoromethyl)quinoline
C11H7BrF3NO (304.96630680000004)
5-bromo-N-(tert-butyl)-2-Methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
5-Bromo-2-(3-methyl-5-(trifluoromethyl)-1H-pyrazol-1-yl)pyridine
C10H7BrF3N3 (304.97753980000005)
3-Bromo-N-butyl-5-methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
3-Bromo-N-(tert-butyl)-N-methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
4-Bromo-N-(tert-butyl)-3-methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
2-Bromo-6-(3-methyl-5-(trifluoromethyl)-1H-pyrazol-1-yl)pyridine
C10H7BrF3N3 (304.97753980000005)
3-bromo-N,N-diethyl-4-methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
3-Bromo-N,N-diethyl-5-methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
4-Bromo-N,N-diethyl-3-methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
2-(2,6-DICHLOROBENZYL)THIAZOLE-4-CARBONYL CHLORIDE
C11H6Cl3NOS (304.92356760000007)
N-BUTYL 3-BROMO-4-METHYLBENZENESULFONAMIDE
C11H16BrNO2S (305.00850560000003)
3-Bromo-N-pentylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
7-Nitro-9-oxo-9H-fluorene-2-sulfonic acid
C13H7NO6S (304.99940820000006)
2,3-cyclic UMP(1-)
C9H10N2O8P- (305.01747700000004)
A 2,3-cyclic nucleotide(1-) which is obtained from 2,3-cyclic UMP by removal of a proton from the cyclic phosphate group.
Iodohippuric acid i-131
C1446 - Radiopharmaceutical Compound > C2124 - Radioconjugate
2-(2,3,3-Trichloro-1-nitroprop-2-enylidene)-1,3-dihydrobenzimidazole
C10H6Cl3N3O2 (304.95255860000003)
5-((5-(4-Fluoro-2-hydroxyphenyl)furan-2-yl)methylene)thiazolidine-2,4-dione
alpha-D-ribose 1-methylphosphonate 5-phosphate(3-)
2-(5-Bromo-2-furanyl)-6-methyl-3,1-benzoxazin-4-one
C13H8BrNO3 (304.96875180000006)
Taminadenant
Taminadenant (NIR178; PBF509) is a highly potent and orally active adenosine A2A receptor (A2AR) antagonist. Taminadenant can antagonize A2AR agonist-mediated cAMP accumulation and impedance responses with KB values of 72.8 nM and 8.2 nM, respectively. Taminadenant reverses motor impairments in several rat models of movement disorders, including catalepsy, tremor, and hemiparkinsonism. Taminadenant can also inhibit tumor growth when combined with Spartalizumab (HY-P9972). Taminadenant reactivate the antitumor immune response[1][2].